LAVA Therapeutics (LVTX) Institutional Ownership $1.31 +0.08 (+6.50%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.32 +0.01 (+0.76%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$2.11MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$455.67K Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Two Sigma Investments LP48,772$46K0.0%-52.5%0.186% 2/17/2025Sanofi1,919,455$1.83M1.0%N/A7.301% 2/17/2025Sphera Funds Management LTD.126,328$120K0.0%-13.7%0.481% 2/17/2025BNP Paribas Financial Markets41,800$40K0.0%N/A0.159% 11/20/2024Virtu Financial LLC19,103$32K0.0%N/A0.075% 11/15/2024Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000% 11/14/2024Walleye Capital LLC14,762$25K0.0%-42.5%0.000% 10/8/2024 Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404% 8/12/2024XTX Topco Ltd30,807$55K0.0%N/A0.122% 7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022UBS Oconnor LLC75,000$343K0.0%N/A0.296% 10/28/2022Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Citadel Advisors LLC60,442$918K0.0%N/A0.238% 5/18/2021Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021Caas Capital Management LP30,000$456K0.0%N/A0.118% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% 5/14/2021Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward) LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, 9 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were Sanofi ($1.83M), Bruce & Co. Inc. ($1.12M), Pathway Financial Advisors LLC ($170K), Sphera Funds Management LTD. ($120K), XTX Topco Ltd ($55K), Two Sigma Investments LP ($46K), and BNP Paribas Financial Markets ($40K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: Sanofi ($1.92M), Bruce & Co. Inc. ($571.87K), Pathway Financial Advisors LLC ($102.50K), BNP Paribas Financial Markets ($41.80K), XTX Topco Ltd ($30.81K), and Virtu Financial LLC ($19.10K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 2,685,539 shares in the last 24 months. This purchase volume represents approximately $3.10M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($241.25K), Two Sigma Investments LP ($53.99K), and Walleye Capital LLC ($10.91K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 306,161 shares in the last 24 months. This volume of shares sold represents approximately $455.67K in transactions. Related Companies Coherus BioSciences Major Shareholders FitLife Brands Major Shareholders Eupraxia Pharmaceuticals Major Shareholders Editas Medicine Major Shareholders Neumora Therapeutics Major Shareholders Instil Bio Major Shareholders Procaps Group Major Shareholders Fate Therapeutics Major Shareholders Enanta Pharmaceuticals Major Shareholders Tonix Pharmaceuticals Major Shareholders This page (NASDAQ:LVTX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LVTX Stock Free LVTX Stock Alerts